Gelatin Hydrogel Microspheres Enable Pinpoint Delivery of Basic Fibroblast Growth Factor for the Development of Functional Collateral Vessels
- 23 November 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (21) , 3322-3328
- https://doi.org/10.1161/01.cir.0000147779.17602.18
Abstract
Background— Various growth factors promote collateral vessel development and are regarded as promising for the treatment of vascular occlusive diseases. However, an efficacious delivery system for them has yet to be established. We devised a strategy to augment functional collateral vessels by using acidic gelatin hydrogel microspheres (AGHMs) incorporating basic fibroblast growth factor (bFGF). The aim of the present study was to investigate the hypothesis that by intra-arterial (IA) administration of bFGF-impregnated AGHMs, bFGF could be delivered from AGHMs trapped in distal small-diameter vessels and thereby induce functional collateral vessels with an assured blood supply through the process of arteriogenesis. Methods and Results— Various sizes of AGHMs (3 mg) incorporating 125 I-labeled bFGF were injected into the left internal iliac artery of a rabbit model of hindlimb ischemia. Less than 50% of radioactivity accumulated in the ischemic hindlimb after injection of AGHMs that were 10 μm in diameter, whereas ≈80% of radioactivity was counted in the ischemic limb after administration of 29- or 59-μm-diameter AGHMs. Calf blood pressure ratio and the ratio of regional blood flow of the bilateral hindlimbs immediately before and after IA administration of 29-μm–diameter AGHMs showed no significant change. Then we evaluated the function of the developed collateral vessels 28 days after IA administration of bFGF-impregnated, 29-μm-diameter AGHMs. IA administration of bFGF-impregnated AGHMs induced marked collateral vessel improvement compared with IA administration of phosphate buffered saline–treated AGHMs and intramuscular administration of bFGF-impregnated AGHMs. Conclusions— IA administration of bFGF-impregnated, 29-μm-diameter AGHMs strongly induced functional collateral vessels without worsening ischemia, indicating the possible therapeutic usefulness of this approach.Keywords
This publication has 22 references indexed in Scilit:
- Involvement of the Fibroblast Growth Factor System in Adaptive and Chemokine-Induced ArteriogenesisCirculation Research, 2003
- Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2Circulation, 2002
- Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulationThe FASEB Journal, 2002
- Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemiaGene Therapy, 2001
- The delivery of angiogenic factors to the heart by microsphere therapyNature Biotechnology, 1998
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.Journal of Clinical Investigation, 1994
- A Persistent Hindlimb Ischemia Model in the RabbitJournal of Investigative Surgery, 1994
- Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardiumJournal of the American College of Cardiology, 1993
- Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factorJournal of Vascular Surgery, 1992
- Enzymatic Radioiodination of GonadotropinsJournal of Clinical Endocrinology & Metabolism, 1972